Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2019-12-08 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于回购股份的债权人通知公告
Transaction in Own Shares Classification · 95% confidence The document is a notification announcement regarding the company's share repurchase plan and a creditor notice related to the repurchase. It details the board resolution approving the share buyback, the intended use of repurchased shares, the price and quantity limits, and instructions for creditors to submit claims within a specified period. The document does not contain financial statements or detailed financial data but is an official announcement about the share repurchase and creditor notification. This fits the category of a Transaction in Own Shares (POS) filing, which covers announcements of share buybacks or sales by the company itself. The document length is short (1576 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is POS with high confidence.
2019-12-08 Chinese
2019年第二次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2019 second extraordinary general meeting (临时股东大会) of the company. It details the legal compliance of the meeting's call, attendance, voting procedures, and results, including approval of share repurchase proposals. The document does not contain financial statements or management discussion of financial results, nor is it a report of financial performance. It is not an announcement of voting results in a brief form but a detailed legal opinion on the meeting's legality and procedures. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal compliance document related to shareholder meeting procedures and voting, not a direct voting results announcement (DVA) or a management or financial report. The document length (7015 characters) and content confirm it is a full legal opinion rather than a short announcement or notice.
2019-12-08 Chinese
2019年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2019 second extraordinary general meeting of shareholders of the company. It includes information about the meeting date, attendance, voting results on various proposals including a share repurchase plan, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and decisions made at the shareholders' meeting rather than the meeting materials or presentations themselves. The document length is about 4768 characters, which is sufficient to contain substantive voting results and details. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-12-08 Chinese
关于召开2019年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2019 second extraordinary general meeting of shareholders for the company. It includes information about the meeting date, voting procedures (both in-person and online), agenda items such as amendments to the company bylaws and a share repurchase plan, registration details, and proxy voting instructions. There are no financial statements or management discussion and analysis present. The document serves as a notice and procedural guide for the shareholders to participate in the meeting and vote on proposals. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2019-12-02 Chinese
关于回购股份事项股东大会股权登记日前十名股东和前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from a company regarding the shareholder register on the record date for a shareholders' meeting related to a share repurchase plan. It lists the top ten shareholders and top ten unrestricted shareholders with their shareholdings and percentages. The document references a share repurchase plan and the shareholders' meeting but does not contain financial statements or detailed financial results. It is primarily about shareholding details in relation to a share buyback. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document length is about 2500 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is POS with high confidence.
2019-12-01 Chinese
中信建投证券股份有限公司关于公司回购股份之独立财务顾问报告
Transaction in Own Shares Classification · 100% confidence The document is titled as an "Independent Financial Advisor Report" regarding the share repurchase plan of Chengdu Berry Genomics Co., Ltd. It extensively discusses the share buyback scheme, including the number of shares to be repurchased, pricing, funding sources, impact analysis on company operations and financials, compliance with regulatory rules, and independent financial advisor opinions. The document is detailed and contains financial data and analysis related to the share repurchase. It is not a simple announcement but a comprehensive advisory report on the share repurchase transaction. This fits the category of a Transaction in Own Shares (POS) report, which covers company buyback activities. The document is not an earnings release, annual report, or capital/financing update but specifically focuses on the share repurchase plan and its implications.
2019-11-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.